CVIA Journal

Cardiovascular Innovations and Applications

29th great wall International conference GWICC

ESC @ GW-ICC Joint Forum – Great Wall International Congress of Cardiology (GW-ICC) 2017- Interventional Cardiology and Acute Coronary Syndromes

It has become a tradition for world renowned cardiology associations to send delegations to GW-ICC congresses.

Professor Jeroen J. Bax, President, European Society of Cardiology (ESC), Professor John Warner, President, American Heart Association (AHA), and Professor Mary N. Walsh, President, American College of Cardiology (ACC), led delegations attending the 28th GW-ICC, to present latest international guidance, cutting-edge diagnosis and information on treatment with emerging technologies.

Cooperation with these international societies is not limited to their attendance at GW-ICC; GW-ICC also holds reciprocal academic sessions at the annual meetings of these eminent societies, for example GW-ICC @ ACC, GW-ICC @ AHA, and GW @ ESC, to introduce important Chinese academic research.

At the 28th GW-ICC in 2017, the ESC @ GW-ICC Joint Forum, which was held over four sessions, focused on the highlights of 2017 ESC Congress, to introduce the latest guidance and discuss the latest developments of ESC images, heart disease, heart failure, STEMI and valve disease.

A video of one of these 2017 sessions is now available to view on the GW-ICC YouTube channel:

Interventional Cardiology and Acute Coronary Syndromes

Presenter: Marco Roffi, Geneva University Hospitals, Geneva, Switzerland.

 

In this presentation Professor Roffi discusses reviews Interventional Cardiology and Acute Coronary Syndromes topics from ESC 2017 with the following take home messages:

  • Decision about the optimal revascularization strategy of complex multivessel CAD should take into account age and clinical profile; anatomic complexity and probability for achieving complete functional revascularization, and access to contemporary drug eluting stents.
  • With contemporary PCI, de-escalation of long term antithrombotic therapy either chronic DAPT in ACS or dual therapy among selected patients with atrial fibrillation appears to be safe and associated with net clinical benefit.
  • The ESC 0/1h algorithm for rapid rule out/in of acute MI is safe and effective and should be extensively implemented.
  • Patients with ACS are changing over time: and older age and more comorbidities may account for complications and a worse outcome.
  • Younger women with STEMI have a higher mortality as compared with men, even when they receive the appropriate treatment in a timely fashion.

 

Further information on the 29th GW-ICC, to be held October 11th -14th, 2018, in Beijing, China, is available on the congress website:

http://www.gw-icc2017.org/en/1/index.jsp

Cardiovascular Innovations and Applications (CVIA) is the official journal of the Great Wall International Cardiology Conference (GW-ICC). CVIA supports GW-ICC in its aims of leading the development of cardiovascular medicine in China, by introducing and promoting new concepts and technologies and strengthening and promoting cooperation amongst Chinese and international cardiology experts. CVIA is available on the IngentaConnect platform http://www.ingentaconnect.com/content/cscript/cvia and at http://cvia-journal.org/. Submissions may be made using Scholar One manuscripts at https:/mc04.manuscriptcentral.com/cvia-journal. There are no author submission or article processing fees.

Twitter: @CVIA_Journal

Facebook: https://www.facebook.com/cvia.journal/

Conference website: http://www.gw-icc2017.org/en/1/index.jsp

Updated: July 16, 2018 — 10:59 am
Cardiovascular Innovations and Applications is indexed in the ESCI, OCLC, Primo Central (Ex Libris), Sherpa Romeo, NISC (National Information Services Corporation), DOAJ and Index Copernicus Databases
EX-Lib-90x50 OCLC-90x50 sherpa NISC logo
Directory of Open Access Journals index-copernicus logo
CVIA Journal © 2015